Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Day One Biopharmaceuticals Inc. Common Stock
DAWN | US
21.20
USD8.42
65.88%
DAWN | US
About Day One Biopharmaceuticals Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
06/03/2026
Close
21.20
Open
21.13
High
21.23
Low
21.08
Day One Biopharmaceuticals Inc. a clinical-stage biopharmaceutical company develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101 an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals Inc. was incorporated in 2018 and is headquartered in Brisbane California.
View LessDAWN | US
Risk
247.8
Sharpe
1.10
Luna's Score
55/100
Recommendation
Hold
Luna says (DAWN | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
345.7%1 month
247.8%3 months
170.8%6 months
132.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.83
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
-7.18
Ent. to rev.
136.82
PEG
-
Other Fundamentals
EBITDA
-287.17M
MarketCap
2.08B
MarketCap(USD)
2.08B
Div. yield
-
Op. margin
-1.40K
Erngs. growth
-
Rev. growth
-
Ret. on equity
-45.71
Short ratio
17.48
Short perc.
19.36
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
11.26
Range1M
11.26
Range3M
13.33
Volumes: Market Activity
Rel. volume
13.14
Price X volume
1.66B
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.18 | - | Cheaper |
| Ent. to Revenue | 136.82 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.83 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 170.85 | - | Riskier |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 2.08B | - | Emerging |
